Shares of IonQ surged 8.1% to $62.55 after Horizon Quantum Holdings announced it would install IonQ's next-generation 256-qubit trapped-ion system at its European headquarters in Dublin — a system the company anticipates will be "one of the most advanced commercial quantum systems in the world." The rally builds on a blowout first quarter and a broader wave of government-backed quantum spending, but the stock's sky-high price tag demands scrutiny.
A Real Customer Buying a Real Machine Matters More Than It Sounds
Horizon Quantum, a Singapore-based quantum software company, announced on June 11 that Dublin would host its second quantum computer testbed.
The IonQ 256-qubit system will complement a superconducting machine already operating in Singapore. For IonQ, this is tangible hardware revenue — a system sale, not just a cloud-access deal — and the initiative is backed by Ireland's National Semiconductor Strategy , lending it government credibility. Each system sale converts IonQ's technology roadmap into bookable income.
Record Revenue Is Real, But the Losses Are Enormous
IonQ posted its third consecutive quarter of record revenue in Q1 2026, hitting $64.7 million — up 755% year-over-year.
Management raised full-year 2026 revenue guidance to $260–$270 million. Yet adjusted EBITDA (a measure of cash profitability) was negative $96.75 million , and stock-based compensation alone ran $128.5 million in the quarter.
The company held $3.1 billion in cash , giving it a long runway — but investors are subsidizing heavy spending on a technology that remains pre-commercial at scale.
The Valuation Leaves Almost No Room for Error
IonQ's market cap sits around $21.6 billion — roughly 80 times its raised full-year revenue guidance midpoint of $265 million. Morningstar pegs fair value at just $31.89 , well below today's price. Remaining performance obligations — essentially contracted future revenue — hit a record $470 million , providing some visibility, but the stock is pricing in years of flawless execution in a field where competitors including IBM and Google are spending billions.
Europe Opens a Strategic Front
International revenue already accounts for about 35% of IonQ's sales , and the Dublin deal deepens that footprint in a market where EU governments are actively funding quantum infrastructure. Winning a hardware placement inside a partner's testing lab also creates a long-term software and services relationship — recurring touchpoints that could outlast a single system sale.
The bottom line: IonQ's commercial traction is accelerating fast, but at 80× revenue the stock is a bet that quantum computing will graduate from laboratories to boardrooms before the cash runs dry.